Lam Research Corporation vs Microsoft Corporation — Stock Comparison
Q·Score Breakdown
8.6
Strong Buy
Overall
8.9
Strong Buy
Quality
Health
Growth
Valuation
Sentiment
LRCX
Earnings growing 41% year-over-year on 24% revenue growth.
MSFT
Analysts see 42% upside to $570.72 consensus target.
Analyst Consensus
BUY
Target $307.74 (+20.6%)
31 analysts
BUY
Target $570.72 (+41.6%)
54 analysts
Fundamentals
LRCX
MSFT
48.2×
Trailing P/E
25.3×
32.6×
Forward P/E
21.0×
30.9%
Profit Margin
39.0%
50.0%
Gross Margin
68.6%
66.8%
ROE
34.4%
23.8%
Revenue Growth
16.7%
40.8%
Earnings Growth
59.8%
1.79
Beta
1.11
—
Price / Book
—
$319.2B
Market Cap
$3.00T
$71 – $276
52-Week Range
$356 – $555
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load.